Caroline Baumal - Jan 4, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Medical Officer
Signature
/s/ David Watson, attorney-in-fact for Caroline Baumal
Stock symbol
APLS
Transactions as of
Jan 4, 2024
Transactions value $
-$165,207
Form type
4
Date filed
1/5/2024, 04:14 PM
Previous filing
Jan 5, 2023
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$165K -2.75K -7.71% $60.05 32.9K Jan 4, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on a Restricted Stock Unit release.